Leonard L. Mazur, Executive Chairman at Citius Pharmaceuticals, Inc. (CTXR), bought 2,234,700 shares at $0.90 ($2.0M) on 2019-09-27, disclosed to the SEC on 2019-09-27.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| CTXR | BUY | 2018-08-15 | $8.0M | — | Filing → |
| CTXR | BUY | 2018-04-02 | $1.0M | — | Filing → |
| CTXR | BUY | 2018-01-08 | $2.0M | — | Filing → |